\
&
Contact us
\
&
Contact us
Published on | 5 years ago
Programmes Food Energy Transport Climate/Environment Batteries Circular Industries Horizon 2020The Green Deal call will mobilise research and innovation to foster a just and sustainable societal transition aiming at ‘leaving nobody behind’. Projects are expected to deliver tangible and visible results relatively quickly and show how research and innovation can provide concrete solutions for the Green Deal main priorities.
The Commission gives the opportunity to help to shape the call by taking part in the surveys, one for each area (11 in total).
Deadline for submission is 3 June 2020.
All information can be found here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
